Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6991, Issue , 2008, Pages

  Ona, Toshihiro ^a   Nishijima, Hiroshi ^a   Kosaihira, Atsushi ^a   Shibata, Junko ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Japan Science and Technology Agency   (Japan)

Author keywords

Apoptosis; Cancer drug; Cell based assay; Personal therapeutic potential; Screening; Surface plasmon resonance

Indexed keywords

BIOTECHNOLOGY; CELL DEATH; CELLS; CHEMOTHERAPY; DETECTORS; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; HEALTH; HEALTH CARE; MICROFLUIDICS; NANOSTRUCTURED MATERIALS; SENSORS; SURFACE PLASMON RESONANCE;

APOPTOSIS; BIO PHOTONICS; CANCER DRUGS; CELL CYCLING; CELL-BASED; CELL-BASED ASSAYS; D ALLOSE; HIGH PRECISION; IN-VITRO; LIVER CANCERS; PHOTONIC; QUANTITATIVE EVALUATION METHODS; REACTION ANALYSIS; ROSCOVITINE (CYC202); SENSOR CHIPS; TUMOR DEVELOPMENT;

CHEMICALS;

EID: 44949254123     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.780819     Document Type: Conference Paper

References (22)

1. American Cancer Association, [Cancer Facts & Figures 2008], American Cancer Society, Atlanta (2008).
2. Los, M., Burek, C. J., Stroh, C., Benedyk, K., Hug, H. and Mackiewicz, A., "Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design," Drug Disc, Today 8(2), 67-77 (2003).
3. Dobashi, Y., Takehama, T., and Ooi, A., "Perspectives on cancer therapy: cell cycle blockers and pertubators," Curr. Med. Chem. 10(23), 2549-2558 (2003).
4. Rothenberg, M. L., Carbone, D. P. and Johnson, D. H., "Improving the evaluation of new cancer treatments: challenges and opportunities," Nat. Rev. Cancer 3(4), 303-309 (2003).
5. Sidransky, D., "Emerging molecular markers of cancer," Nat. Rev. Cancer 2(3), 210-219 (2002).
6. González, J. E. and Negulescu, P. A., "Intracellular detection assays for high-throughput screening," Curr. Opin. Biotechnol. 9(6), 624-631 (1998).
7. Cooper, M. A., "Optical biosensors in drug discovery," Nat. Rev. Drug Discov. 1(7), 515-528 (2002).
8. Raether, H., [Surface plasmons on smooth and rough surfaces and on gratings], Springer, Berlin (1983).
9. Kosaihira, A. and Ona, T., "Rapid and quantitative method for evaluating the personal therapeutic potential of cancer drugs," Anal. Bioanal. Chem., in submission.
10. Traxler, P., "Tyrosine kinases as targets in cancer therapy-successes and failures," Expert Opin. Ther. Targets 7(2), 215-234 (2003).
11. Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A. and Pandol, S. J., "Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis," Int. J. Cancer 98(5), 761-769 (2002).
12. Gehm, B. D., McAndrews, J. M., Chien, P. Y. and Jamieson, J. L., "Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor," Proc. Natl. Acad. Sci. USA 94(25), 14138-14143 (1997).
13. She, Q. B., Ma, W. Y., Wang, M., Kaji, A., Ho, C. T. and Dong, Z., "Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved," Oncogene 22(14), 2143-2150 (2003).
14. Moore, P. S., Sipos, B., Orlandini, S., Sori, C., Real, F. X., Lemoine, N. R., Gress, T., Bassi, C., Klöppel, G., Kalthoff, H., Ungefroren, H., Löhr, M. and Scarpa, A., "Genetic profile of 22 pancreatic carcinoma cell lines: analysis of K-ras, p53, pl6 and DPC4/Smad4," Virchows Arch 439(6), 798-802 (2001).
15. Nylander, C., Liedberg, B. and Lind, T., "Gas detection by means of surface plasmon resonance," Sens. Actuators 3(1), 79-88 (1982/1983).
16. Sui, S., Dong, Y., Watanabe, Y., Yamaguchi, F., Hatano, N., Tsukamoto, I., Izumori, K. and Tokuda, M., "The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation," Int. J. Oncol. 27(4), 907-912 (2005).
17. Sui, S., Dong, Y., Watanabe, Y., Yamaguchi, F., Hatano, N., Tsukamoto, I., Izumori, K. and Tokuda, M., "Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro," Anticancer Res. 25(4), 2639-2644 (2005).
18. Wȩsierska-Ga̧lek, J., Gueorguieva, M., Wojciechowski, J. and Horky, M., "Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine," Pol. J. Pharmacol. 56(5), 635-641 (2004).
19. Monaco III, E. A., Beaman-Hall, C. M., Mathur, A. Vallano, M. L., "Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons," Biochem. Pharmacol. 67(10), 1947-1964 (2004).
20. Wojciechowski, J., Horky, M., Gueorguieva, M. and Wȩierska- Ga̧dek, J., "Rapid onset of Nuclear disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells," Int. J. Cancer 106(4), 486-495 (2003).
21. Salvioli, S., Ardizzoni, A., Franceschi, C. and Cossarizza, A., "JC-1, but not DiO6(3) or rhodamine 123, is a reliable fluorescent probe to assess Δψ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis," FEBS Let. 411(1), 77-82 (1997).
22. Downward, J., "Cancer biology: signatures guide drug choice," Nature 439(7074), 274-275 (2006).